[PMID: 15212755] Laboratory literature summary: Supplementation of L-carnitine in athletes: does it make sense
Brito, of the Mayo Clinic, looked at data from January 1, 2014 to December 31, 2021 on 351,913 patients who started taking either a GLP-1 drug, a sodium-glucose cotransporter 2 inhibitor (SGLT2i) like Jardiance or Farxiga, dipeptidyl peptidase-4 inhibitor (DPP4i) like Januvia and Onglyza, or a sulfonylurea such as Glucotrol
Research indicates that the peptide may: Increase fat breakdown Improve energy use from stored fat Support gradual weight reduction However, it is important to understand that AOD-9604 is not a miracle fat-loss compound
doi: 10.5501/wjv.v10.i2.34 69 DrgeW
About this article Cite this article Wang, X., Cai, Y., Wu, C